GI & Endoscopy

CMS has issued its final National Coverage Determination for the colorectal cancer stool DNA test Cologuard, developed by Exact Sciences.

The addition of bevacizumab (Avastin) to chemotherapy for the treatment of metastatic colorectal cancer may not be cost-effective, according to a report from Gastroenterology & Endoscopy News.

National guidelines for endoscope cleaning may be updated due to research performed by University of Pittsburgh Medical Center’s infection prevention team, according to a Medical Xpress report.

Gastroenterologists are facing more and more demands on their time, while striving to maintain excellence. Four gastroenterologists share tips on improving GI practice efficiency without affecting quality of care.

With accountable care organizations and population health on the rise, a premium is placed on preventative care. Colorectal cancer screening has been a central focus in healthcare and gastroenterology for years, with a significant pay off, but more remains to…

A balloon colonoscope improves polyp and adenoma detection rate when compared to standard colonoscopy, according to a Medscape report.

Here are three gastroenterologists who made the news within the past week.

Serge Haan, a professor in the Life Science Research Unit at the University of Luxembourg, and his colleagues have discovered two potential biomarkers for colorectal cancer, according to a Medical News Today report.

The FDA has approved the new cranberry flavored PREPOPIK bowel preparation from Ferring Pharmaceuticals.

Recent research has found that malpractice claims for delayed diagnosis of esophageal cancer in low-risk patients is uncommon, according to a Gastroenterology & Endoscopy News report.